1. Home
  2. ACLS vs AAPG Comparison

ACLS vs AAPG Comparison

Compare ACLS & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$85.85

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$23.66

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
AAPG
Founded
1995
2009
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ACLS
AAPG
Price
$85.85
$23.66
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$101.50
$48.50
AVG Volume (30 Days)
1.1M
1.4K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.80
N/A
Revenue
$839,048,000.00
N/A
Revenue This Year
$5.54
N/A
Revenue Next Year
$1.72
$368.64
P/E Ratio
$21.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.40
$17.56
52 Week High
$102.93
$48.45

Technical Indicators

Market Signals
Indicator
ACLS
AAPG
Relative Strength Index (RSI) 50.15 41.89
Support Level $78.05 $23.06
Resistance Level $98.97 $26.55
Average True Range (ATR) 4.85 0.91
MACD -0.23 0.15
Stochastic Oscillator 45.01 34.64

Price Performance

Historical Comparison
ACLS
AAPG

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: